Related Experiment Video

Updated: May 8, 2026

Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK

Hag Dong Kim1, Su-Jin Yu, Hee Suk Kim

  • 1From the Department of Biochemistry, Korea University College of Medicine, Seoul 136-705.

The Journal of Biological Chemistry
|August 13, 2013
PubMed

Insights

Interleukin-4 (IL-4) triggers cellular senescence and inhibits growth in renal cell carcinoma (RCC) by activating STAT6 and p38 MAPK pathways. These pathways independently contribute to IL-4

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Interleukin-4 (IL-4), a known lymphocyte growth factor, exhibits direct tumor cell growth inhibitory properties.
  • Previous research indicated IL-4 induces G1 phase cell cycle arrest in human renal cell carcinoma (RCC) via p21(WAF1/CIP1) upregulation.
  • The precise mechanisms underlying IL-4-mediated growth inhibition in RCC require further elucidation.

Purpose of the Study:

  • To investigate the molecular mechanisms responsible for Interleukin-4 (IL-4)-induced growth inhibition in human renal cell carcinoma (RCC).
  • To determine the role of Signal Transducer and Activator of Transcription 6 (STAT6) and p38 Mitogen-Activated Protein Kinase (MAPK) in IL-4's effects on RCC cells.

Main Methods:

  • Treatment of human RCC cell lines with Interleukin-4 (IL-4).
  • Assessment of cellular senescence markers, including morphology and senescence-associated-β-galactosidase (SA-β-gal) staining.
  • Analysis of Signal Transducer and Activator of Transcription 6 (STAT6) and p38 MAPK activation and their involvement using inhibition and silencing techniques.
  • Evaluation of p21(WAF1/CIP1) expression levels following IL-4 treatment and pathway modulation.

Main Results:

  • Interleukin-4 (IL-4) induced cellular senescence in four of six human RCC cell lines.
  • Both Signal Transducer and Activator of Transcription 6 (STAT6) and p38 MAPK were activated by IL-4 and mediated growth inhibition and senescence.
  • Inhibition of either STAT6 or p38 MAPK partially reduced IL-4's effects, while combined inhibition almost completely abrogated them, indicating independent pathways.
  • IL-4-induced p21(WAF1/CIP1) upregulation was also additively attenuated by silencing both STAT6 and p38 MAPK.

Conclusions:

  • Interleukin-4 (IL-4) induces cellular senescence and growth inhibition in a subset of human renal cell carcinoma (RCC) cell lines.
  • The signaling pathways involving Signal Transducer and Activator of Transcription 6 (STAT6) and p38 Mitogen-Activated Protein Kinase (MAPK) independently mediate these IL-4 effects.
  • These findings highlight potential therapeutic strategies targeting STAT6 and p38 MAPK in IL-4-responsive RCC.
Keywords:
IL-4InterleukinRenal Cell CarcinomaRenal PhysiologySTAT Transcription FactorSTAT6Senescencep21WAF1/CIP1p38 MAPK

More Related Videos

Induction and Validation of Cellular Senescence in Primary Human Cells08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...